Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease

• मुख्य लेखकों: Laurie L. Baggio (लेखक), Daniel J. Drucker (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2021-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Glucagon-like peptide-1 receptor (GLP-1R) agonists are approved to treat type 2 diabetes and obesity. They elicit robust improvements in glycemic control and weight loss, combined with cardioprotection in individuals at risk of or with pre-existing cardiovascular disease. These attribute...